US · Healthcare

Alpha Tau Medical Ltd (DRTS)

Biotechnology

Alpha Tau Medical Ltd (DRTS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DRTS

P/E ratio

25.00

Alpha Tau Medical Ltd (DRTS) — FAQ

What is DRTS's P/E ratio?

The price-to-earnings (P/E) ratio for Alpha Tau Medical Ltd (DRTS) is 25.00 (data as of 2026-05-23).

Does Alpha Tau Medical Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Alpha Tau Medical Ltd (DRTS). Check the MyAverix Finance app for the latest dividend data.

What sector is Alpha Tau Medical Ltd in?

Alpha Tau Medical Ltd (DRTS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DRTS listed on?

DRTS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)